Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Correction: Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

    Katsuyoshi Matsuoka, Hajime Yamazaki, Masakazu Nagahori in Journal of Gastroenterology (2024)

  2. Article

    Open Access

    Real-world NUDT15 genoty** and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study

    This study evaluated the effectiveness of NUDT15 codon 139 genoty** in optimizing thiopurine treatment for inflammatory bowel disease (IBD) in Japan, using real-world data, and aimed to establish genotype-ba...

    Motoki Makuuchi, Yoichi Kakuta, Junji Umeno in Journal of Gastroenterology (2024)

  3. No Access

    Article

    Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria

    Hospitalization for ulcerative colitis (UC) is potentially life-threatening. Severe disease in the Japanese criteria which modifies the Truelove–Witts’ criteria might encompass more fulminant cases than the de...

    Makoto Naganuma, Naohiro Nakamura, Reiko Kunisaki in Journal of Gastroenterology (2024)

  4. No Access

    Article

    A combination of bowel wall thickness and submucosa index is useful for estimating endoscopic improvement in ulcerative colitis: external validation of the Kyorin Ultrasound Criterion

    Endoscopic improvement (EI; a Mayo endoscopic subscore of 0 or 1) is considered a therapeutic target in ulcerative colitis (UC) treatment. The potential to estimate EI non-invasively is an advantage of intesti...

    Haruka Komatsu, Hiromu Morikubo, Yoko Kimura, Chihiro Moue in Journal of Gastroenterology (2024)

  5. Article

    Open Access

    Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis

    Predicting the therapeutic response to biologics before administration is a key clinical challenge in ulcerative colitis (UC). We previously reported a model for predicting the efficacy of vedolizumab (VDZ) fo...

    Hiromu Morikubo, Ryuta Tojima, Tsubasa Maeda, Katsuyoshi Matsuoka in Scientific Reports (2024)

  6. No Access

    Article

    Life-threatening gastrointestinal bleeding caused by perforation of a penetrating atherosclerotic ulcer into the esophagus

    We present a case of life-threatening gastrointestinal bleeding caused by a penetrating atherosclerotic ulcer (PAU) that ruptured into the esophagus. A 65-year-old man presented with pyrexia and nausea. Contra...

    Yoko Kimura, Kenji Nakamura, Daiki Kojima in Clinical Journal of Gastroenterology (2023)

  7. No Access

    Article

    Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis

    This multicenter observational cohort study aimed to evaluate the utilization and short-term efficacy of advanced therapy (AT) in hospitalized patients with acute severe ulcerative colitis (ASUC).

    Makoto Naganuma, Taku Kobayashi, Reiko Kunisaki in Journal of Gastroenterology (2023)

  8. No Access

    Article

    Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT

    The degree of immune response to COVID-19 vaccination in inflammatory bowel disease (IBD) patients based on actual changes in anti-SARS-CoV-2 antibody titres over time is unknown.

    Kenji Watanabe, Masanori Nojima, Hiroshi Nakase in Journal of Gastroenterology (2023)

  9. Article

    Open Access

    Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study

    The YOu and Ulcerative colitis: Registry and Social network (YOURS) is a large-scale, multicenter, patient-focused registry investigating the effects of lifestyle, psychological factors, and clinical practice ...

    Katsuyoshi Matsuoka, Hajime Yamazaki, Masakazu Nagahori in Journal of Gastroenterology (2023)

  10. Article

    Open Access

    5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis

    Although many therapeutic options are available for inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) is still the key medication, particularly for ulcerative colitis (UC). However, the mechanism...

    Haruka Wada, Jun Miyoshi, Satoshi Kuronuma, Yuu Nishinarita in Scientific Reports (2023)

  11. Article

    Correction: Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)

    Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto in Journal of Gastroenterology (2023)

  12. Article

    Open Access

    Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study

    This ongoing post-marketing surveillance monitors the long-term safety and effectiveness of vedolizumab in routine clinical practice in patients with moderate-to-severe ulcerative colitis (UC) in Japan. This i...

    Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Yohei Mikami in Advances in Therapy (2023)

  13. Article

    Open Access

    Plasma free amino acid profiles are associated with serum high molecular weight adiponectin levels in Japanese medical check-up population without type 2 diabetes mellitus

    To prevent the progression of type 2 diabetes mellitus (T2DM), early detection and intervention are important. Several studies have already shown that the serum adiponectin level could be useful for evaluating...

    Kengo Tokunaga, Hidehiro Nakamura, Sakino Toue, Yumiko Kato, Yosuke Ida in Amino Acids (2023)

  14. Article

    Open Access

    Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan

    Takashi Ishige, Toshiaki Shimizu, Kenji Watanabe in Journal of Gastroenterology (2023)

  15. Article

    Open Access

    Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021

    We aimed to develop criteria for treatment intensification in patients with (1) luminal Crohn’s disease (CD), (2) CD with perianal disease and/or fistula, (3) CD with small bowel stenosis, (4) in the postopera...

    Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai in Journal of Gastroenterology (2023)

  16. Article

    Open Access

    Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey

    Given the increasing health concerns for patients with inflammatory bowel disease (IBD), amidst the COVID-19 pandemic, we investigated the impact of the pandemic on the anxiety and behavioral changes in Japane...

    Hiroshi Nakase, Kohei Wagatsuma, Masanori Nojima in Journal of Gastroenterology (2023)

  17. Article

    Open Access

    Expert consensus on vaccination in patients with inflammatory bowel disease in Japan

    Immunosuppressive therapies can affect the immune response to or safety of vaccination in patients with inflammatory bowel disease (IBD). The appropriateness of vaccination should be assessed prior to the init...

    Takashi Ishige, Toshiaki Shimizu, Kenji Watanabe in Journal of Gastroenterology (2023)

  18. No Access

    Article

    Characteristics of adult patients newly diagnosed with Crohn’s disease: interim analysis of the nation-wide inception cohort registry study of patients with Crohn’s disease in Japan (iCREST-CD)

    The Inception Cohort Registry Study of Patients with Crohn’s Disease aimed to clarify clinical characteristics and disease course of newly diagnosed Crohn’s disease patients in Japan throughout a 4-year period...

    Katsuyoshi Matsuoka, Toshimitsu Fujii, Ryuichi Okamoto in Journal of Gastroenterology (2022)

  19. No Access

    Article

    Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis

    The purpose of this study was to clarify the clinical characteristics of spondyloarthritis (SpA) patients with inflammatory bowel disease (IBD) compared to those without IBD. Furthermore, among patients with S...

    Keisuke Ono, Mitsumasa Kishimoto, Gautam A. Deshpande in Rheumatology International (2022)

  20. Article

    Open Access

    A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation

    Many clinical trials have been conducted for inflammatory bowel disease (IBD), so various clinical indices (CIs) and endoscopic indices (EIs) have also been evaluated. However, recently, with the progress of I...

    Masahiro Kishi, Fumihito Hirai, Noritaka Takatsu in Journal of Gastroenterology (2022)

previous disabled Page of 4